Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von J J A van den Dorpel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Center for Lysosomal and Metabolic Diseases, The Netherlands. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Cognition, Magnetic Resonance Imaging, Brain. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Prinses Beatrix Spierfonds, Stichting Metakids, ZonMw.
Abstract (Originalsprache)
The aim of this longitudinal cohort study, is to provide more insight into the pattern of brain abnormalities, and possible consequences for cognitive functioning, in patients with classic infantile Pompe disease. We included 19 classic infantile Pompe patients (median age last assessment 8.9 years, range 1.5–22.5 years; 5/19 CRIM negative), treated with ERT. Using MR imaging of the brain (T1, T2, and FLAIR acquisitions), we classified progression of brain abnormalities on a 12‐point rating scale at multiple time points throughout follow‐up. Additionally we noted specific white matter patterns and examined atrophy. Cognitive development was studied using Wechsler IQ assessments obtained by certified neuropsychologists. The association between age and cognitive functioning, and MRI ratings and cognitive functioning was assessed by linear regression models. All but one patient developed brain abnormalities. The abnormalities progressed in a similar pattern throughout the brain, with early involvement of periventricular white matter, later followed by subcortical white matter, gray matter structures, and juxtacortical U‐fibers. We found a significant decline ( p < 0.01), with increasing age for full scale IQ, performance IQ and processing speed, but not for verbal IQ ( p = 0.17). Each point increment in the 12‐point MRI rating scale was associated with a significant decline (3.1–6.0 points) in all the IQ index scores ( p < 0.05). The majority of long‐term surviving patients in our cohort develop incremental brain MRI abnormalities and decline in cognitive functioning. This highlights the need for new therapies that can cross the blood–brain barrier in order to treat this CNS phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Center for Lysosomal and Metabolic Diseases, The Netherlands.
- Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
- Department of Neurology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
- Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
- Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Center for Lysosomal and Metabolic Diseases, The Netherlands.
- Department of Child and Adolescent Psychiatry/Psychology, Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
ORCID-Profile: J J A van den Dorpel
Förderung
- Prinses Beatrix Spierfonds
- Stichting Metakids
- ZonMw
- Sophia Foundation for Medical Research
- For Wis(h)dom Foundation
- LSH-TKI
- Stichting Ziekte van Pompe
Zitieren
APA
van den Dorpel, J. J. A., Mackenbach, M. J., Dremmen, M. H. G., van der Vlugt, W. M. C., Rizopoulos, D., van Doorn, P. A., van der Ploeg, A. T., Muetzel, R., van der Beek, N. A. M. E., & van den Hout, J. M. P. (2024). Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12736
Vancouver
van den Dorpel JJA, Mackenbach MJ, Dremmen MHG, van der Vlugt WMC, Rizopoulos D, van Doorn PA, et al. Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12736
BibTeX
@article{vandenDorpel2024,
author = {van den Dorpel, J J A and Mackenbach, M J and Dremmen, M H G and van der Vlugt, W M C and Rizopoulos, D and van Doorn, P A and van der Ploeg, A T and Muetzel, R and van der Beek, N A M E and van den Hout, J M P},
title = {Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12736}
}
EUVIMED